Analytical Data
-
Gene name
TNXB
- Application
-
Alternative Names
(TN-X)(Hexabrachion-like protein)
-
Species
Human
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P22105
-
Expression Region
1-673aa
-
Molecular Weight
81.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TNXB, or Tenascin-XB, is an extracellular matrix protein that plays a crucial role in tissue structure and function. It belongs to the tenascin family of proteins, which are implicated in various biological processes including cell adhesion, migration, and differentiation during embryonic development and tissue repair. Research into TNXB has gained prominence due to its association with connective tissue disorders, particularly Ehlers-Danlos syndrome, which is characterized by hypermobility, skin elasticity, and tissue fragility. The study of TNXB and its recombinant protein forms has significant potential for therapeutic applications, including regenerative medicine and the development of biomaterials for tissue engineering. By understanding TNXB's structure-function relationship, researchers aim to uncover its mechanistic role in pathologies and explore its applications in regenerative therapies. The development of recombinant TNXB proteins allows for detailed study of their biological functions and interactions with cells and other matrix components, paving the way for innovative strategies to treat connective tissue disorders and enhance tissue repair processes. As such, TNXB is a promising candidate for biotechnological endeavors aimed at improving human health and understanding the complexities of extracellular matrix dynamics.
